The people of Dayton are facing unprecedented economic challenges. The first step in addressing the healthcare affordability ...

Type 2 diabetes, obesity may have a link with late-night eating – especially close to bedtime, according to research results.

A new study strongly suggests that low doses of weight loss drugs like Ozempic can counteract aging in middle aged mice.

First-of-its-kind AI-powered chronic care management platform moves clinically proven tools outside the doctor's office ...

The challenges facing rural health are sizable – which is why the solutions require scale.  Virtual care is already making a ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

The autoimmune disorder destroys the body’s ability to produce insulin. Some patients in experimental trials have gotten it ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

This article was reviewed by Darragh O’Carroll, MD. Diabetes Medications for Weight Loss: What to Know Key takeaways: Some medications FDA-approved for type 2 diabetes can … ...

On the opening Monday of EASD 2025 in Vienna, Professor Lori Laffel, Dr. Guido Freckmann, and Professor Julia Mader were invited to share their researches collaborated with iCanTM CGM. The symposium ...

CLEVELAND, Ohio — When artificial intelligence provides health-coaching to adults with Type 2 diabetes, it can significantly improve their ability to control blood sugar, a new Cleveland Clinic study ...